Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects
Clinical trial NCT04053023 · COMPLETED
Trial details
- NCT number
- NCT04053023
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-27
- Primary completion
- 2019-11-25
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.